Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Sai Yin Cheung"'
Autor:
Yuefeng Wang, Julia Y. S. Tsang, Yongmei Cui, Ji Cui, Ying Lin, Songli Zhao, Patrick T. W. Law, Sai Yin Cheung, Enders K. O. Ng, Gary M. K. Tse, Zunfu Ke
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
Abstract Currently, there are no recommended alternative assays for HER2 cases deemed equivocal by immunohistochemistry and fluorescent in situ hybridization. Digital PCR (ddPCR), a highly accurate method to determine DNA copy number, could be a robu
Externí odkaz:
https://doaj.org/article/781a188a1d1d475190ab60b6d48f3515
Autor:
Joshua J. Li, Siu-Ki Chan, Jintao Hu, Gary Tse, Julia Y. Tsang, Chaiwat Aphivatanasiri, Ivan K. Poon, Shirley K. Jamidi, Sai-Yin Cheung
Publikováno v:
Histopathology. 77:936-948
AIMS Confirmation of a breast origin for triple-negative breast cancer (TNBC) is sometimes problematic. The traditional breast markers GATA-binding protein 3 (GATA3), mammaglobin (MGB) and gross cystic disease fluid protein 15 (GCDFP15) have shown li
Autor:
Siu-Ki Chan, Ivan K. Poon, Ronald C. K. Chan, Ka Fai To, Shirley K. Jamidi, Yan Shao, Fiona K Tam, Joshua Li, Julia Y. Tsang, Sai-Yin Cheung, Chaiwat Aphivatanasiri, Ka-Ho Shea, Gary Tse, Joanna Tong
Publikováno v:
Breast Cancer Research and Treatment. 184:11-21
For invasive breast cancer (IBC), high SOX10 expression was reported particularly in TNBC. This raised the possibility that SOX10 may complement other breast markers for determining cancers of breast origin. Here, we compared the expression of SOX10
Autor:
Siu-Ki Chan, Ivan K. Poon, Julia Y. Tsang, Ka-Ho Shea, Fiona K Tam, Billy Shui-Wun Lai, Sai-Yin Cheung, Yan Shao, Gary M. Tse
Publikováno v:
Oncologist
The latest World Health Organization (WHO) classification categorized invasive breast carcinomas (IBCs) with neuroendocrine (NE) differentiations into neuroendocrine neoplasms (including well-differentiated neuroendocrine tumor [NET] and poorly diffe
Publikováno v:
Pathology. 53(2)
Insulinoma associated protein 1 (INSM1) is a relatively new marker of neuroendocrine differentiation. It has been shown to have a high sensitivity for neuroendocrine tumours arising from different organs. This study evaluated INSM1 as a marker for ne
Autor:
Yun-Bi Ni, Ming Liu, Jintao Hu, Hong Hu, Gary Tse, Michelle Lee, Julia Y S Tsang, Siu-Ki Chan, Sai-Yin Cheung
Publikováno v:
Journal of Clinical Pathology. 71:1007-1014
AimsIn breast cancer models, the functional roles of CD147 in proliferation, invasion and treatment resistance have been widely reported. However, there are only a few studies examining the clinicopathological correlation and prognostic relevance of
Autor:
Ka Fai To, Gary Tse, Siu-Ki Chan, Yun-Bi Ni, Sai-Yin Cheung, Joanna H.M. Tong, Michelle A. Lee, Julia Y S Tsang, Xingen Wang
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
PURPOSE Proline, glutamic acid, and leucine-rich protein 1 (PELP1), a novel nuclear receptor (NR) co-regulator, is highly expressed in breast cancer. We investigated its expression in breast cancer subtypes, in comparison with other breast markers as
Autor:
Ava Kwong, Maribel D Lacambra, Michelle A. Lee, Julia Y S Tsang, Cherry Wu, Sai-Yin Cheung, Yun-Bi Ni, Gary Tse, Yau-Kam Hui
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Scientific Reports
Scientific Reports
Phyllodes tumor (PT) of the breast is a rare but clinically important fibroepithelial tumor with potential risks of recurrence and metastasis. Recent studies identified recurrent TERT promoter mutations in PTs. However, the clinical significance of t
Autor:
Thazin Hlaing, Jintao Hu, Siu Ki Chan, Julia Y S Tsang, Xia Liu, Gary M. Tse, Sai Yin Cheung, Yun-Bi Ni
Publikováno v:
The Oncologist. 22:1316-1324
Background The presence of tumor infiltrating lymphocytes (TIL) is associated with favorable prognosis. Recent evidence suggested that not only their density, but also the spatial organization as tertiary lymphoid structures (TLS), play a key role in
Autor:
Siu-Ki Chan, Wai-Ling Au, Jintao Hu, Kui-Fat Chan, Thazin Hlaing, Yun-Bi Ni, Gary Tse, Julia Y S Tsang, Sai-Yin Cheung, Kwan-Yin Lo
Publikováno v:
Breast Cancer Research and Treatment. 162:19-30
Clinical trials showing programmed death (PD)-1–PD-ligand 1 (L1) axis as a promising therapeutic target in melanoma and non-small cell lung cancers have made the pathway a focus of recent attention. However, the data regarding PD-L1/PD-1 in breast